Díaz Luis Antonio, López Marisol, Sin Priscila, Wolff Rodrigo, González Gloria, Muñoz María Paz, Uribe Mario, Ananias Álvaro, Bezama Ignacio, Zañartu Nicolás, Buckel Erwin, Innocenti Franco, Pattillo Juan Carlos, Jarufe Nicolás, Martínez Jorge, Guerra Juan Francisco, Elgueta Susana, Gana Juan Cristóbal
Departamento de Gastroenterología, Pontificia Universidad Católica de Chile, Santiago, Chile.
Departamento de Pediatría, Pontificia Universidad Católica de Chile, Santiago, Chile.
Rev Med Chil. 2020 Sep;148(9):1261-1270. doi: 10.4067/S0034-98872020000901261.
The Chilean allocation system for liver transplantation (LT) uses the MELD/PELD score to prioritize candidates on the waiting list.
To assess if the Chilean allocation system for LT is equitable for pediatric candidates compared to their adult counterparts.
We used the Public Health Institute's registry between October 2011 and December 2017. We analyzed candidates with chronic hepatic diseases listed for LT. The primary outcome was the cadaveric liver transplantation (CLT) rate. Secondary outcomes were death or disease progression in the waiting list and living donor liver transplant (LDLT) rate.
We analyzed 122 pediatric and 735 adult candidates. Forty one percent of pediatric candidates obtained a CLT compared to 48% of adults (p = NS). Among patients aged under two years of age, the access to CLT on the waiting list there was 28% of CLT, compared to 48% in adults (p = 0.001). Fifty-seven percent of candidates aged under two years were listed for cholestatic diseases, obtaining a CLT in 18% and requiring a LDLT in 49%. The median time in the waiting list for CLT was 5.9 months in pediatric candidates and 5.1 in adults, while the median time to death in the waiting list was 2.8 and 5.6 months, respectively. The mortality rate at one year in candidates under two years old was 38.1% compared to 32.5% in adults.
Pediatric candidates with chronic liver diseases, especially under two years of age, have greater access difficulties to CLT than adults. Half of the pediatric candidates die on the waiting list before three months. The mortality among candidates under two years of age in the waiting list is excessively high.
智利的肝移植(LT)分配系统使用终末期肝病模型(MELD)/小儿终末期肝病模型(PELD)评分对等待名单上的候选人进行优先级排序。
评估智利的LT分配系统对儿科候选人与成人候选人相比是否公平。
我们使用了公共卫生研究所2011年10月至2017年12月期间的登记数据。我们分析了列入LT名单的慢性肝病候选人。主要结局是尸体肝移植(CLT)率。次要结局是等待名单上的死亡或疾病进展以及活体肝移植(LDLT)率。
我们分析了122名儿科候选人和735名成人候选人。41%的儿科候选人接受了CLT,而成人接受CLT的比例为48%(p = 无显著差异)。在两岁以下的患者中,等待名单上接受CLT的比例为28%,而成人接受CLT的比例为48%(p = 0.001)。两岁以下的候选人中有57%因胆汁淤积性疾病列入名单,其中18%接受了CLT,49%需要接受LDLT。儿科候选人接受CLT的等待名单中位时间为5.9个月,成人为5.1个月,而等待名单上的中位死亡时间分别为2.8个月和5.6个月。两岁以下候选人的一年死亡率为38.1%,而成人死亡率为32.5%。
患有慢性肝病的儿科候选人,尤其是两岁以下的儿童,获得CLT的难度比成人更大。一半的儿科候选人在等待名单上三个月内死亡。两岁以下候选人在等待名单上的死亡率过高。